• AI-Driven Radiopathomics Predicts Immunotherapy Response in

  2026-07-20

  This study presents a multimodal radiopathomics signature (RPS) developed using interpretable machine learning to predict response to immunotherapy-based combination therapy in gastric cancer. Integrating CT and digital pathology data, the RPS outperforms conventional biomarkers and reveals new insights into immune regulation, offering a robust tool for patient stratification and treatment planning.

• Idoxuridine: Precision Antiviral Workflows for DNA Synthesis

  2026-07-19

  Idoxuridine (5-iodo-2'-deoxyuridine) is a benchmark antiviral agent for dissecting viral DNA synthesis and replication inhibition, enabling robust, reproducible workflows in both classic and emerging research domains. This article translates cutting-edge findings and expert troubleshooting into actionable protocols, highlighting APExBIO’s research-grade Idoxuridine as the gold standard for antiviral and mechanistic studies.

• PYR-41, Inhibitor of Ubiquitin-Activating Enzyme E1: Advance

  2026-07-18

  PYR-41, a selective inhibitor of Ubiquitin-Activating Enzyme E1, revolutionizes research on protein degradation and inflammatory signaling by enabling precise, reproducible control of the ubiquitin-proteasome system. This article delivers actionable experimental workflows, advanced troubleshooting, and practical insights for leveraging PYR-41 in cutting-edge cellular and in vivo models.

• EdU Imaging Kits (488): Advancing S-Phase DNA Synthesis Meas

  2026-07-17

  EdU Imaging Kits (488) elevate cell proliferation assays by enabling non-destructive, highly sensitive S-phase DNA synthesis detection using click chemistry. Their streamlined workflow and superior preservation of cell morphology distinguish them from BrdU-based methods, making them an optimal choice for advanced research in cancer biology and regenerative medicine.

• Disrupting SARS-CoV-2 N Protein Phase Separation With GCG: M

  2026-07-17

  The referenced study uncovers how the SARS-CoV-2 nucleocapsid (N) protein undergoes RNA-triggered liquid–liquid phase separation (LLPS), a critical process for viral replication and assembly. It further demonstrates that (-)-gallocatechin gallate (GCG) can inhibit this phase separation, thereby suppressing viral replication—offering a mechanistic foundation for antiviral strategy development.

• Novel Phenylethanoid Glycosides from Forsythia: Isolation an

  2026-07-16

  The referenced study systematically identified and structurally characterized new and known phenylethanoid glycosides—including Forsythoside E—from the fruits of Forsythia suspensa. This foundational work enables mechanistic exploration and practical application of Forsythoside E as a selective PKM2 inhibitor and immunometabolic modulator in inflammation and sepsis research.

• BMPSB4-Induced Autophagy Suppresses Corticotroph PitNETs via

  2026-07-16

  This study demonstrates that the BMP4 pathway agonist BMPSB4 activates autophagy through SMAD1/5/9 phosphorylation, leading to potent inhibition of corticotroph pituitary neuroendocrine tumors (PitNETs) associated with Cushing's disease. The findings highlight a mechanistic link between BMP4 signaling and autophagy-mediated tumor suppression, offering a promising direction for therapeutic development in aggressive or recurrent PitNETs.

• MLKL Polymerization Drives Lysosomal Cathepsin B Release in

  2026-07-15

  The reference study establishes that polymerization of MLKL at lysosomal membranes induces lysosomal membrane permeabilization (LMP), resulting in cytosolic release of cathepsin B and execution of necroptosis. Chemical inhibition or genetic knockdown of cathepsin B significantly protects cells from necroptotic death, highlighting a critical mechanistic link between MLKL activation, lysosomal disruption, and regulated cell death.

• Flubendazole (SKU B1759): Reliable Autophagy Modulator for C

  2026-07-15

  This article addresses real-world challenges in autophagy modulation research for cancer biology, with a focus on using Flubendazole (SKU B1759) to ensure reproducibility and data integrity. Scenario-driven Q&A blocks guide biomedical researchers and lab technicians through optimized workflows, protocol considerations, data interpretation, and product selection, emphasizing evidence-based strategies. Explore how Flubendazole from APExBIO bridges practical gaps in assay design and delivers consistent results.

• PDK4-IN-1 Hydrochloride: Redefining Mitochondrial Metabolism

  2026-07-14

  Discover how PDK4-IN-1 hydrochloride, a potent pyruvate dehydrogenase kinase 4 inhibitor, enables advanced mitochondrial metabolism studies. This article provides unique mechanistic insights and protocol guidance beyond standard resources.

• GSTA1 Drives Glutathione Depletion in α-Amanitin Liver Injur

  2026-07-14

  This study uncovers a paradoxical mechanism in which upregulated GSTA1, rather than protecting hepatocytes, accelerates glutathione depletion and exacerbates oxidative stress in α-amanitin-induced liver injury. The findings reframe GSTA1’s role in hepatotoxicity and highlight its potential as a direct therapeutic target in acute poisoning scenarios.

• NBC19: Precision NLRP3 Inflammasome Inhibitor for Inflammati

  2026-07-13

  NBC19 sets a new benchmark for NLRP3 inflammasome inhibition, offering nanomolar IC50 in cellular models and robust suppression of IL-1β release. Its stability, workflow flexibility, and reproducibility make NBC19 a top choice for dissecting inflammation and metastatic niche biology.

• BAPTA Calcium Chelator: Mechanisms, Benchmarks & Application

  2026-07-13

  BAPTA is a high-affinity calcium chelator used to modulate intracellular Ca2+ signaling in cell and biochemical assays. It enables precise dissection of calcium-dependent pathways, including apoptosis via the IP3R/Ca2+/STAT3 axis. This dossier details BAPTA's mode of action, evidence base, workflow integration, and practical limitations.

• Remdesivir (GS-5734): Mechanistic Insights and Assay Precisi

  2026-07-12

  Explore how Remdesivir (GS-5734) revolutionizes coronavirus antiviral research by bridging mechanistic insights with practical assay optimization. This article uniquely connects structural advances in viral polymerase biology to the design of more predictive in vitro workflows.

• EdU Imaging Kits (488): Precision Cell Cycle Quantification

  2026-07-10

  Explore how EdU Imaging Kits (488) unlock high-fidelity analysis of S-phase DNA synthesis and cell proliferation in cancer research. This article delivers advanced insights on assay optimization, mechanistic details, and translational relevance, setting it apart from prior content.

8514 records 8/568 page Previous Next First page 上5页 678910 下5页 Last page